PC-JUN24-PG26.1_Layout 1 13/06/2024 11:18 Page 26
CHEMICALS & PHARMACEUTICALS
SINGLE-USE SOLUTIONS FOR SPECIFIC NEEDS
Watson-Marlow Fluid Technology Solutions has launched
WMArchitect single- use fluid path management
solutions to optimise biopharmaceutical fluid management
his flexible, single-use solutions range has been developed by building on years of experience, and is designed to streamline a biopharmaceutical company’s process, safeguard its product and reduce its regulatory burden.
T
The new end-to-end, single-use fluid path management solution consists of: Single-use assemblies are custom- designed to meet a company’s specific requirements. The open architecture model allows full flexibility and compatibility with existing fluid-contact materials used in a company’s bioprocess. Single-use fluid transfer assemblies are ready-to-use, pre-designed assemblies, all with lot traceable tubing and components, which optimise fluid transfer between equipment and process steps. They can be selected from a menu of validated components. Fill/finish single-use assemblies that safeguard therapeutic products during the filling process with a wide range of sterility- assured assembly configurations. Representative assemblies are routinely tested for bioburden, particulates and endotoxin.
Validation testing specialists from WMFTS support users of WMArchitect with bioprocessing expertise and tailored validation packages to help reduce a
company’s regulatory burden.
WMFTS works with its customers to ensure complete confidence in product quality and sterility assurance.
Nicole Hunter, Head of Global WMArchitect, said: “By listening to the evolving needs of our biopharmaceutical customers, we have created WMArchitect to provide an expert solution that supports them in mitigating their regulatory and supply chain risks.
“WMFTS understands that often, off-the-shelf products are merely a starting point. We customise our standard products to provide a complete and tested solution from a single supplier that is tailored to meet a company’s specific requirements.
“WMArchitect is ideal for high purity biopharmaceutical process development, clinical trials and small to large scale production batches.
“We recognise that the most critical component for maximising performance is where the tubing meets the pump. Our assembly solutions are designed
synergistically with our best-in-class Watson- Marlow peristaltic pump technologies and filling solutions. With quality built-in, our complete solutions ensure reliable, repeatable performance for your most sensitive processes.”
All WMArchitect single-use solutions are manufactured, pre-assembled and packaged at WMFTS’ global network of Class 7 cleanrooms. The WMFTS global supply network provides uninterrupted supply security and robust lead times. By partnering with WMArchitect, biopharmaceutical companies can be confident that supply will keep pace as their business grows.
To ensure our single-use technology comes ready to use, and meets the requirements set by current good manufacturing practice (cGMP) guidelines, lot traceability of each component can be made available as part of our detailed documentation.
A dedicated WMArchitect business unit and additional resources allow for rapid turn- around from a supplier that will keep pace as their customers business grows. Benefits and features: • Complete confidence in product quality • Designed to reduce a biopharmaceutical company’s validation burden
• Support of internal validation protocols • Flexible integration with an open architecture approach
• Use in conjunction with Watson-Marlow peristaltic pumps or Flexicon filling systems for an end-to-end fluid management solution • Supply security with WMFTS’ global manufacturing and supply network
Watson-Marlow Fluid Technology Solutions
www.wmfts.com
26 JUNE 2024 | PROCESS & CONTROL
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56
